Forty Seven Inc. Reports Second Quarter 2019 Financial Results and Recent Business Highlights
-- Presented Updated Data for 5F9 in Four Patient Populations at ASCO and EHA Meetings -- -- Received FDA Feedback Suggesting Single-Arm Pivotal Trials May Support Registration in MDS and DLBCL -- -- Entered Exclusive Licensing Agreement with Ono …